Our studies support the hypothesis that the ADAR1 gene product inhibits HIV-1 replication in human macrophages and likely produces the high frequency of A to G mutation found in HIV-1/TB co-infected patients after aerosol IFN-γ treatment. Here, IFNG is linked to tuberculosis.